Related by context. All words. (Click for frequent words.) 94 PEG PAL PEGylated recombinant 81 acetylgalactosamine 6 80 6 sulfatase 79 include GALNS N 79 GALNS N acetylgalactosamine 74 XL# anticancer compounds 74 targeting Inflammatory Bowel 74 include PLX IBD 74 MKC# MT 73 Frozen Shoulder syndrome Adhesive 73 MPS IVA 73 pralatrexate injection folate analogue 73 products MKC# PP 72 modified glutathione analog 72 MKC# 71 Disease IBD 71 dependent kinase inhibitor 71 sapropterin dihydrochloride Phase 71 AAG geldanamycin analog 71 R roscovitine CDK cyclin 70 Acetavance TM intravenous acetaminophen 70 orally administered inhibitor 70 Capsulitis 70 mGluR5 negative 70 ionotropic glutamate receptor antagonists 70 inflammatory autoimmune diseases 70 dihydrochloride Phase 3 70 oral proteasome inhibitor 70 Azedra TM Onalta TM 70 VEGFR2 inhibitor 69 2 methoxyestradiol 69 TKB# 69 oral nucleoside analogue 69 Auxilium transmucosal film 69 neuropathic pain metabolic diseases 69 OAB overactive bladder 69 Kuvan TM sapropterin 69 delivers fluocinolone acetonide FA 69 Solazed TM 69 somatropin Kuvan R 69 TRIOLEX ™ 69 allosteric modulator NAM 69 alfimeprase direct 69 Zemiva ™ 69 phenylketonuria PKU developed 68 pulmonology portfolio 68 induced mucositis 68 REMOXY POSIDUR ELADUR 68 Seliciclib CYC# 68 Luramist TM 68 Zemiva TM Trofex TM 68 non porcine pancreatic 68 oncolytic virus therapies 68 MKC# MKC# PP 68 Panzem R 68 diaper dermatitis complicated 68 Luveris R Ovidrel R 68 Empatic TM 68 candidate AQ4N 68 Staphylococcus aureus Immune Globulin 68 novel VDA molecule 68 Telik logo TELINTRA 68 pentadentate logo R 68 IMPDH inhibitor 68 TRANSDUR ® 68 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 68 muscarinic receptor agonists 68 PDX pralatrexate 68 Ovitrelle R Serostim 68 product platforms AZX# 68 dihydrochloride Tablets 68 Intermezzo ® zolpidem tartrate 68 overactive bladder AA# 68 polysaccharide polymer 68 hypoxia activated prodrug 68 lintuzumab SGN 68 6R BH4 68 topical antifungal product 68 markets Testim ® 68 topically applied SEPA 67 muscarinic receptor agonist 67 Zemiva TM 67 rusalatide acetate 67 Custirsen 67 sapropterin dihydrochloride Tablets 67 2 inhibitor CYT# 67 novel antifolate currently 67 candidate REP# 67 candidate XP# 67 sapropterin dihydrochloride 67 transthyretin mediated amyloidosis ATTR 67 include Phenoptin TM 67 By CHRIS WOODKA 67 cardiometabolic diseases Glucophage 67 RH1 targeted chemotherapeutic agent 67 NOTE POSIDUR ™ 67 ALN PCS 67 brand eszopiclone XOPENEX 67 CYP#A# CYP#D# 67 Veronate R 67 oxybutynin ATD TM 67 nanofiltered plasma derived 67 non alcoholic steatohepatitis 67 rheumatoid arthritis thrombocytopenia 67 highly purified pasteurized 67 R famotidine 67 TELINTRA R 67 CDK cyclin dependent 67 NU# direct 67 cancer indications bafetinib 67 include Altastaph TM 67 EVIZON TM squalamine lactate 67 Solzira TM 67 metabolic disorders Saizen R 67 essential thrombocythemia ET 67 thrombin component 66 R Saizen R 66 topical gel formulation 66 CD# CEA 66 Trubion proprietary 66 pan histone deacetylase 66 omecamtiv mecarbil formerly 66 vitreoretinal disorders 66 molecular imaging radiopharmaceutical 66 clinical trials Archexin 66 Cytogen marketed 66 Adagen ® 66 AFFECT MICROSEMI 'S 66 WILL PROVE TO BE 66 interferon beta 1a infertility 66 dimebon latrepirdine 66 individualized cellular immunotherapy 66 Crofelemer budesonide foam 66 developing Bicifadine serotonin 66 R brand eszopiclone 66 Initiates Phase II 66 Amigal TM 66 NASH Huntington 66 Augment TM 66 clinical trials dacetuzumab SGN 66 mecarbil 66 toenail onychomycosis 66 R metformin Concor 66 pipeline GlycoPEG GCSF 66 TM testosterone gel 66 TRIOLEX HE# APOPTONE HE# 66 Locteron ® 66 Wafer polifeprosan 66 personalized cellular immunotherapy 66 familial amyloidotic polyneuropathy FAP 66 HYVISC ® treatment 66 HuCAL PLATINUM ® CysDisplay 66 Solution XOPENEX HFA 66 AND ACTUAL RESULTS 66 Anturol ® 66 SinuNase TM 66 CONTAINS FORWARD LOOKING STATEMENTS 66 candidate MyVax 66 Aurexis R 66 ELADUR TM 66 FOLOTYN ® 66 migraine headaches neuropathic pain 66 novel L DOS# 66 non nucleoside inhibitor 66 Personalized Immunotherapy 66 Pruvel TM 65 VYVANSE TM lisdexamfetamine 65 CYT# potent vascular disrupting 65 leading oral taxane 65 Tezampanel 65 evaluating picoplatin 65 MANAGEMENT 'S CURRENT BELIEFS 65 ™ testosterone gel 65 dioxide boron trichloride 65 orBec R oral beclomethasone 65 CysDisplay R 65 HCl PEPCID ® famotidine 65 TRANSDUR ™ 65 human C1 inhibitor 65 Gel repository corticotropin injection 65 GlycoPEGylated hemostasis compounds 65 R MSCRAMM 65 relapsed leukemia 65 Potassium Chloride Sodium Ascorbate 65 ELADUR ™ 65 hyperphenylalaninemia HPA due 65 Trial Evaluating 65 THESE STATEMENTS FOR REVISIONS 65 Vitrasert R 65 Ovidrel R Ovitrelle R 65 methylnaltrexone bromide 65 specifically hypoactive sexual 65 IS FOR INFORMATIONAL 65 neuropathic pain spasticity 65 Serostim R 65 Oral NKTR 65 targeted radiotherapeutic 65 neuromuscular spasm 65 proprietary HuCNS SC 65 vascular occlusive diseases 65 INSPIRE Trial Phase III 65 samarium Sm 65 novel orally inhaled 65 R bortezomib 65 investigational oral inhibitor 65 Empatic ™ 65 AAG KOS 65 sodium glucose cotransporter 65 candidates Azedra 65 Avise MCV SM 65 diarrhea predominant irritable 65 GVAX ® 65 telomerase therapeutic 65 peptidic compound 65 ARE MADE AS 65 CB2 selective receptor agonist 65 myocardial infarction ventricular fibrillation 65 oral dihydropyrimidine dehydrogenase DPD 65 LUNESTA ® 65 Peyronie disease Frozen Shoulder 65 Prodarsan R 65 DepoCyt ® Abelcet ® 65 Epothilone D 65 including eniluracil ADH 65 Completes Enrollment 65 diabetes mellitus autoimmune disorders 65 candidates Augment ™ 65 CTAP# Injection 65 THE OFFER DOCUMENTS 65 markets COLAZAL 65 Medipoints 65 ALN HPN 65 markets HP Acthar 65 colorectal bladder 65 Cardium Therapeutics TM 65 Novel Oral 65 MCSP respectively 65 Sciences ABthrax Albuferon 65 PEGylated Fab fragment 65 using VIAdel TM 65 R chorionic gonadotropin 65 CAREFULLY READ THESE MATERIALS 65 clinical trials Archexin ® 65 PINNACLEDIGEST.COM S PAST PERFORMANCE 65 TO BE ACCURATE 65 Completes Patient Enrollment 65 Kit CD# positive 65 TELIK 65 targets Galectin receptors 65 sodium thiosulfate STS 64 therapeutically inactive prodrug 64 active AKT inhibitor 64 sores onychomycosis nail 64 acetonide FA 64 SHALL NOT CONSTITUTE AN 64 documented candidiasis 64 diarrhea fatigue asthenia 64 refractory chronic lymphocytic 64 AN OFFER OF 64 Hemispherx flagship products 64 oral ghrelin agonist 64 ENTIRETY IF AND 64 Oral Solution OSMOPREP 64 ALTROPANE R 64 PNP inhibitor 64 Xcytrin R 64 BiovaxID TM 64 Initiates Phase 64 Pruvel ™ prulifloxacin 64 treat refractory angina 64 QUADRAMET R 64 BCG refractory carcinoma 64 THE TIME PROVIDED 64 IMiDs R 64 Receives Orphan Drug Designation 64 LymphoStat B belimumab 64 COULD DIFFER MATERIALLY FROM 64 Alseres Cethrin 64 Kuvan R 64 influenza BCX# purine nucleoside 64 HepeX B TM 64 aldehyde dehydrogenase ALDH2 deficiency 64 systemic juvenile idiopathic 64 VERIFICATION OF THE 64 IS BEING MADE ONLY 64 sublingual tablet formulation 64 estrogen receptor beta agonist 64 catheter occlusion 64 REPRONEX R menotropins 64 ABL inhibitor completing 64 lexidronam injection 64 synthetic lipoglycopeptide antibiotic 64 male hypogonadism licensed 64 Alfacell proprietary ribonuclease 64 XP# XP# 64 Iluvien ® 64 gastrointestinal disorders ATI 64 brand ciclesonide HFA 64 palonosetron hydrochloride Injection Dacogen 64 OR REVISE ANY FORWARD 64 PMX # antibiotic 64 delta gamma agonist 64 ARE PRESENTED FOR INFORMATIONAL 64 anti botulism antibody 64 inflammatory PDE 64 novel topoisomerase 64 INFORMATION CONTAINED HEREIN 64 Avise PG SM 64 FACTORS THAT CAN MATERIALLY 64 THOSE ANTICIPATED IN 64 ACCURATE AS ACTUAL RESULTS 64 development peramivir neuraminidase 64 Isis# where 64 developing ostarine selective 64 antiangiogenesis therapies 64 AND FUTURE EVENTS 64 R sorafenib tablets 64 navigator.appName & navigator.appName.indexOf Netnavigator.appVersion.indexOf 2 64 rilonacept Injection 64 WRX STi +# mins 64 Solazed ™ 64 topical anti infective 64 BY CHRIS HUGHES 64 Commences Phase 64 TNF Tumor Necrosis Factor 64 candidate ridaforolimus 64 treat chronic sinusitis 64 KRYSTEXXA TM pegloticase 64 hyperplasia BPH 64 dasatinib Sprycel ® 64 GATTEX ™ 64 occlusion PAO 64 RISKS UNCERTAINTIES AND OTHER 64 ARE REASONABLE THERE CAN 64 R lenalidomide 64 ocular formulation 64 sorafenib tablets 64 particularly SANCTURA XR 64 hemorrhagic colitis development 64 delta opioid receptor 64 INFORMATION AS 64 ACCORDINGLY READERS SHOULD NOT 64 ARE ONLY PREDICTIONS 64 approved incretin mimetic 64 所 的 64 protein ADNP 64 candidates Azedra TM 64 但是 64 PMX # heptagonist 64 pan HDAC inhibitor 64 Dyax logo 64 IS NOT INDICATIVE OF 64 很多 64 infectious diseases autoimmune diseases 64 hyaluronic acid PERLANE R 64 PLAN OR EXPECT 64 MOVIPREP R 64 R bisoprolol Euthyrox 64 lexidronam injection PROSTASCINT 64 REGULATORY AUTHORITY HAS APPROVED 64 Nicotine Conjugate Vaccine 64 valtorcitabine 64 refractory gout 64 DEBT AND IDENTITY 64 Testosterone MDTS ® 64 chronic eosinophilic leukemia 64 SPREAD USD 64 Serostim ® 64 Inhalation Aerosol 64 DATE HEREOF 64 OPTIONS THESE FUTURES CHARTS 64 'S FUTURE PLANS 64 * olmesartan medoxomil 64 HAS CHARM AND 64 AND OBJECTIVES OR 63 sodium chlorate electrolytic manganese 63 oxybutynin ATD ™ 63 Daclizumab 63 IMiDs ® 63 Initiates Enrollment 63 Numoisyn R 63 non constipating irritable 63 Initiates Clinical Trial 63 infection epistaxis dyspnea exfoliative 63 IMPORTANT FACTORS THAT COULD 63 WITHIN THE MEANING OF 63 DIURIL R 63 GLP1 INT TM 63 THE GERMAN SECURITIES 63 developing Surfactant Replacement 63 HIV AIDS neuropathic pain 63 AND ARE SUBJECT 63 lead molecular radiotherapeutic 63 vapreotide acetate 63 Meets Primary Endpoint 63 sapacitabine CYC# 63 hepatology portfolio 63 MAY CONTAIN FORWARD LOOKING 63 investigational pharmacologically unique 63 commercializing dermatological products 63 QNEXA ® 63 milnacipran HCI 63 oritavancin semi 63 AS ESTIMATE ANTICIPATE BELIEVE 63 biomimetics non 63 modafinil Tablets C 63 evaluating pirfenidone 63 ARE NOT INDICATIVE OF 63 THOSE CONTAINED IN 63 ARE SUBJECT TO 63 CONTAINS CERTAIN FORWARD LOOKING 63 RECORD CAN COMPLETELY 63 Pharmos proprietary 63 acute peripheral arterial 63 polyneuropathy HIV DSP 63 NEBIDO R 63 derivatives Radilex TM 63 pirate steve video 63 Retisert ® 63 Mylan Receives Approval 63 DNA methyltransferase inhibitors 63 TO DIFFER MATERIALLY THERE 63 label Lipofen R 63 MATTERS DISCUSSED IN 63 Pruvel ™ 63 WITHDRAW ANY ITEM 63 Entereg R 63 candidate SILENOR TM 63 CholeraGarde R Peru 63 WHICH ARE NOT PURELY 63 OBLIGATION TO UPDATE 63 benzoic acid hyoscyamine sulfate 63 CONTROL WHICH MAY CAUSE 63 AND ORAL STATEMENTS MADE 63 ThermoDox ® clinical 63 CHARACTER INTERNALLY WITH EXPOSED 63 FORWARD LOOKING STATEMENTS INVOLVE 63 Tβ4 synthetic copy 63 STATEMENTS CONTAINING FORWARD LOOKING 63 JZP 63 5 HT3 antagonist 63 ITS ENTIRETY BECAUSE 63 Vitamin D analogue 63 Phase 2b Clinical Trial 63 oral dual endothelin 63 Advancing Drugs 63 THE SUBMIT BUTTON 63 oral prodrug 63 novel antimitotic agent 63 Restoraderm R 63 BY JIM HAND 63 myelofibrosis polycythemia vera 63 BY KEVIN LITTEN 63 UNCERTAINTIES OR OTHER FACTORS 63 BY SHARON COOLIDGE 63 Zorbtive TM 63 HeartMate ® 63 male hypogonadism PRO 63 Xolegel Vusion 63 generation URAT1 inhibitor 63 VISICOL R 63 By JUDY SIEGEL 63 IV FENTORA R 63 tiapamil 63 SECURITIES COMMISSION OR OTHER 63 next generation URAT1 63 INFORMATION INCLUDING STATEMENTS RELATING 63 THAT ARE SUBJECT TO 63 Oral Suspension Oral Suspension 63 LES EXPLOSIFS NORDEX LTEE 63 DATA ARE FORWARD 63 RELIANCE UPON ANY FORWARD 63 PLEASE READ THE FOLLOWING 63 DOES SEEKING ALPHA ASSUME 63 ® famotidine 63 PLACE UNDUE RELIANCE ON 63 Inc. ProMetic www.prometic.com 63 injection purified MENOPUR 63 prokinetic agent 63 Phase IIb Trial 63 Budesonide foam crofelemer 63 一直 63 infectious diseases autoimmune 63 STATEMENT CAREFULLY WHEN 63 hypertension osteoarthritis 63 gastrointestinal mucositis 63 RON Notch 63 BY JASON THOMPSON 63 cytopenias due 63 protein tyrosine phosphatase 1B 63 CONTINUED ACCEPTANCE OF 63 THE COMPANY UNDERTAKES NO 63 recurrent metastatic ovarian cancer 63 Phase Ib clinical trials 63 HISTORICAL ARE FORWARD LOOKING 63 d' IRIN sur http:/www.irinnews.org 63 www.artesmedical.com 63 NEWS RELEASE THE COMPANY 63 virus HCV protease inhibitor 63 triggers apoptosis programmed 63 forodesine purine nucleoside phosphorylase 63 BELIEVES THAT THE 63 INTENTIONS CONTAINED IN 63 IN SUCH FORWARD 63 Thiarabine 63 topical non steroidal 63 BY RYAN ERNST 63 REPRONEX ® menotropins 63 PRODUCTS OR PRICING CHANGES 63 PURCHASE INSURANCE 63 vomiting anorexia stomatitis 63 synthetic anti infective 63 OR INFORMATION 63 kaj.leers @ thomson.com 63 navigator.appVersion.indexOf 2 63 orBec ® oral beclomethasone 63 ALN TTR 63 oral isotype selective HDAC 63 Suppository Hydrocortisone Acetate Rectal 63 Unigene nasal calcitonin 63 CRM# Protein 63 SAFE HARBOR PROVISIONS OF 63 CTAP# 63 induced macular edema 63 CAUTIONARY STATEMENT UNDER 63 isolated hypertriglyceridemia 63 BY JAMES MCNAIR 63 Marcus Gronholm BP 63 AND CONSENT SOLICITATION 63 LOOKING STATEMENTS THAT SPEAK 63 BY ROB WEILER 63 mGluR2 positive 63 Cetrorelix 63 OR THE APPLICABLE 63 方面 的 63 Study Evaluating 63 PORxin TM platforms 63 OR OTHER EXPECTATIONS IMPLIED 63 HAS ATTEMPTED TO IDENTIFY 63 Parkinson disease levodopa induced 63 ITS REGULATION PROVIDER AS 63 UNCERTAINTIES AND OTHER FACTORS 63 5 lipoxygenase activating 63 Files IND 63 OR CONTENT CONTAINED THEREIN 63 OTHER THAN PURELY HISTORICAL 63 Romidepsin 63 Curis collaborator Genentech 63 INCLUDES FORWARD LOOKING STATEMENTS 63 CONTAIN FORWARD LOOKING STATEMENTS 63 ARE BEING MADE SOLELY 63 arsenic trioxide injection 63 cough nasopharyngeal pain 63 BY FRANK MORTIMER 63 SPEAK ONLY AS 63 WEB SITE OR 63 Darinaparsin Zinapar TM 63 worsening thrombocytopenia 63 Nventa proprietary CoVal 63 Indibulin Zybulin TM 63 TH STAFF WRITER 63 LOOKING STATEMENTS WHICH INVOLVE 63 ALL PHOTOGRAPHS USED ARE 63 INVESTORS ARE CAUTIONED NOT 63 TO IDENTIFY SUCH FORWARD 63 AND CONDITIONS OF 63 small molecule chemotherapeutic 63 phenyl salicylate methylene blue 63 WAS PREPARED BY KINBAURI 63 BY ANDREW LARSON 63 hyaluronic acid DYNACIN R 63 PURPOSE OF SAFE HARBOR 63 CHECKS WILL NOT BE 62 intravenous ghrelin agonist 62 RECOMMENDATIONS TO PURCHASE SELL 62 PROSTASCINT R 62 minocycline HCl LOPROX R 62 INFORMATION INVOLVE KNOWN AND 62 REDUCED DEMAND FOR 62 Factor Receptor 62 R rilonacept Injection 62 将 的 62 TO BUY OR 62 dyskinesia PD LID 62 Tramiprosate ALZHEMED TM 62 arthritis PsA 62 ANY RESPONSIBILITY FOR ANY 62 phase III isavuconazole 62 DG# compounds targeting 62 或者 62 THe ORIGINAL CREDITOR WITHIN 62 MAY CONSTITUTE FORWARD LOOKING 62 OF WILLIAM JENACK 62 THE AUCTIONEER RESERVES 62 AUCTIONEERS UNAUTHORIZED USE 62 Atrisorb D R 62 Health RxList theHeart.org 62 BY MICHAEL SCHMIDT 62 对 的 62 syndrome overactive bladder 62 lyase enzyme 62 TELINTRA 62 COVER YOUR BODY 62 THE APPLICABLE COMPANY ASSUME 62 IS NOT AFFECTED BY 62 generation DACH Platinum 62 IMPACS TM 62 RESULTS INDICATED OR IMPLIED 62 INFORMATION EXPRESS 62 immuno inflammatory diseases 62 FOLLOWED BY OR 62 MATERIALLY FROM ANY FUTURE 62 BY PETER GOBIS 62 FDA APPROVES 62 OR DISAPPROVED THE 62 BY DAVID LINTON 62 BY SUCH FORWARD 62 Intravenous Human 62 kidney urologic 62 MT# MEDI 62 BY STEVE SHEPPARD 62 必须 62 TRANSDUR TM 62 nephropathic cystinosis cystinosis 62 Nasdaq MNKD focuses 62 BY ERIN MURPHY 62 Phase IIb Clinical Trial 62 THE REPORTING 62 androgen receptor modulator 62 大学 英语 62 include VALSTAR TM 62 LPLD Hemophilia B 62 INCLUDE CHANGES IN 62 ¢ ÃÆ'à † â 62 R DYNACIN R 62 STATEMENTS OF CURRENT 62 PLACE UNDUE IMPORTANCE ON 62 N acetylgalactosamine 6 62 BELIEFS PLANS EXPECTATIONS AND 62 FUSILEV ® 62 MAb therapy 62 psoriasis rheumatoid arthritis 62 BE NO ASSURANCE 62 AND TO REOFFER 62 MBOYER@ENQUIRER.COM 62 pharmacogenomic translational research 62 CTA# Injection 62 PURPOSES ONLY AND DOES 62 BY EDWARD CARIFIO 62 BY DAVID KRECHEVSKY 62 BE ANY SALE 62 AzaSite Xtra 62 BY MICHAEL PUFFER 62 IF PAID PROPERTY 62 MATERIALLY FROM CURRENT EXPECTATIONS 62 nasal calcitonin product 62 ACTUAL RESULTS COULD DIFFER 62 THR beta agonist 62 THE AUCTIONEER HAS 62 BY STEPHANIE A. WILKEN 62 OR REFLECT THE 62 USP Tablets PEPCID 62 By TERESA ANN 62 Pharma Merck Serono 62 SABER ™ 62 PURCHASE LETTER OF TRANSMITTAL 62 Pain Neutralizer holds 62 Lenocta TM 62 bucindolol hydrochloride 62 news.de ein Presseportal der 62 interferon gamma 1b 62 recombinant PSMA vaccine 62 INCLUDE ANY STATEMENTS REGARDING 62 AND CONDITIONS TO 62 AND OTHER RISKS AND 62 hyaluronidase enzyme 62 Merck OSI Pharmaceuticals 62 4SC AG ISIN DE# 62 Long acting beta2 62 Alzheimer disease cognitive dysfunction 62 AWAY FROM WINDOWS 62 BUPHENYL 62 equine osteoarthritis marketed 62 BY MARK FARINELLA 62 Omigard TM omiganan pentahydrochloride 62 DECISION WITH RESPECT TO 62 SOLICITATION WILL PROVIDE COPIES 62 carcinoid syndrome diabetes 62 THESE CONDITIONS NOT 62 HAS BEEN PREPARED BY 62 Vidaza ® 62 tranquilizers diazepam 62 GERD migraine headaches 62 acyclovir Lauriad R 62 BY MICHAEL GELBWASSER 62 YOUR LAPTOP PRINTER DESKTOP 62 STATEMENTS IN 62 PEGylated anti 62 CoTherix logo 62 FBOVESPA 62 PROSPECTUS PROXY STATEMENT BECAUSE 62 cet article est réservé 62 POLYSHIELD ® POLYCLEAR ® 62 including thyroiditis RA 62 Pivotal Phase 62 FUTURE EVENTS OR CIRCUMSTANCES 62 WILL PREVAIL 62 TBC# 62 国家 的 62 MAY DIFFER 62 BY JONATHAN SHUGARTS 62 hypereosinophilic syndrome 62 diabetes irritable bowel 62 RELY UPON THIS 62 四 六级 62 somatostatin analogue 62 TNFerade ™ 62 Syndrome LEMS 62 JECKBERG@ENQUIRER.COM 62 prescription brands RESTYLANE 62 compound PMX # 62 OFFER TO SELL OR 62 bronchospasm dizziness headache 62 PAST RESULTS 62 OR CHANGES 62 THE INFORMATION PROVIDED 62 ACQUISITION AND DEVELOPMENT 62 Presents Preclinical Data 62 ® LYCRA ® 62 方式 62 PURPOSES ONLY AND 62 MADE BASED UPON 62 BLIZZARD WARNING MEANS SEVERE 62 NPSP# parathyroid hormone 62 ® chorionic gonadotropin 62 THAT SPEAK AS 62 acne impetigo 62 THE COMPETITIVE MARKETPLACE 62 BY JOHN MCKENNA 62 Oral Solution VISICOL 62 Provectus Pharmaceuticals specializes 62 OR INTENDED 62 INFORMATION SET FORTH HEREIN 62 因为 62 Palifosfamide 62 STATEMENTS WHICH INCLUDE BUT 62 NEBIDO VANTAS SUPPRELIN LA 62 TRADING ACT 62 Nasdaq XTLB 62 INVESTORS SHOULD NOT 62 NicVAX TM 62 BY DUSTIN DOW 62 考研 62 REPRESENTS THE EXPECTATIONS 62 LONDON FOG R MOSSIMO 62 herpetic keratitis 62 GATTEX TM 62 THOUGHTS EXPRESSED HEREIN WITHOUT 62 XL# XL# XL# XL# 62 THIS ACTION 62 OTHER THAN STATEMENTS OF 62 Phase 2a Clinical Trial 62 Randomized Double blind 62 DIURIL ® Chlorothiazide AZASAN 62 INCLUDE BUT ARE NOT 62 PROVISIONS OF THE PRIVATE 62 candidate Hematide TM 62 OF SECTION #A 62 GVAX R 62 BY MICHELLE SHAW 62 sanofi aventis Bayer Schering 62 MEK Inhibitor 62 trademarks Vitrasert R 62 NEEDS WHICH MAY CAUSE 62 REQUIRED BY APPLICABLE CANADIAN 62 BEFORE PROVISION FOR 62 peripherally acting 62 monoclonal antibody biologic 62 BY THESE FORWARD 62 By THERESA CAMPBELL 62 THAT CAUSE RESULTS 62 CG# oncolytic virus 62 Mg Usa 62 Begins Dosing 62 Through Glycoscience R 62 BASED ON NUMEROUS ASSUMPTIONS 62 Boehringer Ingelheim MedImmune 62 BY ANDY PIPER 62 MAY NOT MATERIALIZE AND 62 OctoPlus licensed 62 Ceragenin ™ 62 INFORMATION RELATING TO 62 OR SIMILAR STATEMENTS ARE 62 bone marrow reticulin deposition 62 DOE Argonne Brookhaven 62 AMONG THE FACTORS THAT 62 报道 说 62 世界 上 62 SECURITY HOLDERS TO READ 62 Phase #b/#a clinical 62 CAUSE ACTUAL RESULTS 62 pseudobulbar affect PBA 62 BY PAUL HUGHES 62 IS NOT AN OFFER 62 MICRODUR TM 62 STATEMENTS WITHIN THE MEANING 62 OF VARIOUS PROJECT 62 THE FUTURES CHARTS 62 PDGFR B 62 systemic lupus erythematosus rheumatoid 62 Serdaxin ® 62 novel synthetic PEGylated 62 huC# DM4 62 cutaneous T 62 孩子 62 #-# rDNA origin 62 Gonal f R 62 REJECT ANY BID 62 NATURE OF THE PROCEEDING 62 口语 62 NO HYPOTHETICAL TRADING 62 * AUD #-YR/#-YR 62 candidate deforolimus 62 RISKS DELAYS AND UNCERTAINTIES 62 Gonal f R follitropin 62 * Azixa 62 REG2 Regado 62 CORDURA ® CORFREE ® 62 BY EILEEN MOZINSKI 62 THAT COULD CAUSE ACTUAL 62 Trouvez d' autres articles 62 AND RELATED LETTER OF 62 Excellarate TM 62 zur Veröffentlichung bereit 62 AND SHOULD ALSO 62 OF THE SUBSTANCE 62 ATTRIBUTING UNDUE CERTAINTY OR 62 BY WILLIAM ROLLER 62 BY PAUL MCKIBBEN 62 AVAILABLE BECAUSE THEY CONTAIN 62 EXPECTATIONS BUT THESE STATEMENTS 62 ® DS methenamine 62 IS DESCRIBED AS 62 PROCTOCORT R 62 candidate Zemiva 62 Emergent marketed 62 studies anatomic pathology 62 Evo +# mins 62 GABITRIL 62 THE OPTION MAY 62 BY AMY DeMELIA 62 他 62 DURECT proprietary 62 OR NATURE 62 BEAMS STONE AND WOODWORK 62 GATTEX ® 62 anti aging glycopeptides 62 Patients Treated With 62 forodesine hydrochloride 62 AzaSite Plus ™ 62 MTP inhibitor 62 RIGHT TO SEEK REMEDIES 62 AND DOES NOT CONSTITUTE 62 NEWS RELEASE CONSTITUTE FORWARD 62 BY MARC SILVESTRINI 62 R DepoCyt 62 metastatic carcinoid 62 INFORMATION CONTAINED IN 62 REPORTS FILED FROM 62 dipropionate 62 MSCRAMM ® 62 可能 会 62 ® SHOWTIME WOMEN 62 ITS CONTENTS 62 Gentamicin Surgical Implant 61 HCV RNA polymerase 61 MSBlast exploits flaw 61 elemental boron 61 SUCH FORWARD LOOKING STATEMENTS 61 atopic dermatitis neonatal 61 rheumatoid arthritis inflammatory bowel 61 Gel BUPHENYL R 61 oral picoplatin 61 WHILE THE COMPANY 61 specific ZFP Nucleases 61 BY REPRESENTATIVES OF 61 allosteric modulator PAM 61 asthma COPD Chronic 61 humanized therapeutic 61 5 lipoxygenase inhibitor 61 AZERBAIJAN HIS EXCELLENCY MR 61 RISKS AND UNCERTAINTIES THAT 61 BY OUR COMPETITORS 61 OR INTENTIONS WILL PROVE 61 THEREFORE ACTUAL RESULTS MAY 61 RELIANCE UPON FORWARD LOOKING 61 Oracea TM 61 OR USE OF 61 Sie lesen Finanznachrichten und 61 IN BAKERS FOOTWEAR 'S 61 IS AVAILABLE LIE FLAT 61 ALSO CALLED 61 AND INFORMATION INCLUDE 61 VERANTWORTLICH 61 Brussels GLPG 61 R#/MEM # 61 一位 61 已经 61 events thrombocytopenia neutropenia 61 SHARPIE FONT 61 OBLIGATION TO REVISE OR 61 BNA THE METEOROLOGY 61 FINANCIAL ADVICE AND 61 CGX ENERGY INC. 61 THAT ARE NOT SENT 61 BY JOE PALLADINO 61 commercialize becocalcidiol patented 61 RapMAT R 61 TO THE COMPANY 61 THAT INCLUDE SUCH WORDS 61 RISKS AND UNCERTAINTIES INHERENT 61 OTHER EXPENSE NET 61 CIMZIA r certolizumab pegol 61 INDIRECT INTERESTS BY 61 CEO www.squeezetrigger.com +#-#-#-# 61 dextromethorphan quinidine 61 CONTAINS FORWARD LOOKING INFORMATION 61 INVESTMENT OR OTHER DECISIONS 61 BY DERRIK MILLER 61 Parkinson disease monogenic diseases 61 ODT metoclopramide HCl PEPCID 61 Dementia Related Psychosis 61 THIS CATALOGUE IS WARRANTED 61 ADDRESS ANY OTHER 61 developing Zerenex TM 61 selective immunoproteasome inhibitor 61 STOCKS AROUND THE 61 TKM ApoB 61 Cannabinor 61 Treppides Tower 6th 61 ATRA IV 61 READ THE DEFINITIVE 61 ACTUAL RESULTS LEVEL OF 61 patented Aganocide compounds 61 DIFICID ™ 61 rheumatoid arthritis RA psoriatic 61 BY JENNIFER EDWARDS 61 ALL MEMORY FOR 61 sodium glucose transporter 61 mtrax@starbeacon.com 61 AN INDICATION OF 61 D. CIMBUREK 61 ONCE AVAILABLE 61 ® decitabine 61 Generx TM 61 investigational compounds 61 unresectable recurrent 61 AND COMPRISES CANOPY PORCH 61 Initiate Phase 61 XL# XL# XL# 61 AN# topical anti 61 BY CHRIS MAYHEW 61 WITH YOUR HANDS 61 CERTAIN RISKS AND UNCERTAINTIES 61 sarcoma melanoma 61 IMPLIED WARRANTIES OR REPRESENTATIONS 61 CHANGES IN SOCIAL POLITICAL 61 BY SCOTT WARTMAN 61 SECTION #A OF 61 Phase III Pivotal 61 humanized anti 61 应该 61 BY SUE KIESEWETTER 61 LEVADEX TM 61 STATEMENTS MADE FROM 61 Alzheimer Disease Parkinson Disease 61 investigating pralatrexate 61 investigational pan BCR 61 PDE4 modulators 61 BY JIM MOORE 61 的 中 61 cosmetic cosmeceutical products 61 Submits NDA 61 Powerwave logo 61 NASDAQ MNKD focuses 61 DATE HEREOF AND 61 EXPECTATIONS AND ARE SUBJECT 61 migraines neurorehabilitation 61 orally absorbed 61 Cyclooxygenase Inhibiting Nitric Oxide 61 aplastic anemia AA 61 R brand arformoterol 61 Mg Uk 61 STATEMENT AND OTHER DOCUMENTS 61 www.BYETTA.com 61 MAY CAUSE THE 61 mark eOn 61 ORDERS PREVIOUSLY STATED IN 61 USE CAREFULLY BEFORE USING